US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

ホーム
投資
株式
オーストラリア
ASX
Amplia Therapeutics Limited (ATXOA) 銘柄情報

Amplia Therapeutics Limited (ATXOA)

0.047

-0.003

(-6.00%)

終了 7月3日 3:00PM

Amplia Therapeutics Limited (ATXOA) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.047

( -6.00% )

買値

0.044

売値

0.047

出来高

155,319

0.047 日の範囲 0.047

0.023 52 週間の範囲 0.23

時価総額

前日終値

0.05

始値

0.047

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 2,646,261

発行済株式数

513,312,014

配当利回り

PER

-8.23

1 株当たり利益 (EPS)

-0.02

歳入

4.79M

純利益

-7.71M

Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in phase 2b clinical trial for pancre... Amplia Therapeutics Limited, a clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia. Its product pipeline comprises Narmafotinib (AMP945), an inhibitor of FAK, which is in phase 2b clinical trial for pancreatic cancer; and treatment of ovarian cancer. It also develops AMP886 for application in oncology and chronic fibrosis indications. The company was formerly known as Innate Immunotherapeutics Limited and changed its name to Amplia Therapeutics Limited in September 2018. Amplia Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.ampliatx.com

本社

Melbourne, Australia

設立

2026

Amplia Therapeutics Limited is listed in the sector of the オーストラリア証券取引所 with ticker ATXOA. The last closing price for Amplia Therapeutics was AUD0.05. Over the last year, Amplia Therapeutics shares have traded in a share price range of AUD 0.023 to AUD 0.23.

Amplia Therapeutics currently has 513,312,014 shares in issue. The market capitalisation of Amplia Therapeutics is AUD24.13 million. Amplia Therapeutics has a price to earnings ratio (PE ratio) of -8.23.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.015	46.875	0.032	0.05	0.032	288440	0.04337081	DE
4	0.012	34.2857142857	0.035	0.05	0.03	212290	0.04104321	DE
12	-0.018	-27.6923076923	0.065	0.082	0.03	192347	0.05246948	DE
26	-0.012	-20.3389830508	0.059	0.135	0.023	339800	0.07678971	DE
52	-0.043	-47.7777777778	0.09	0.23	0.023	447598	0.10221114	DE
156	0.037	370	0.01	0.23	0.009	541188	0.08348644	DE
260	0.037	370	0.01	0.23	0.009	541188	0.08348644	DE

ATXOA - Frequently Asked Questions (FAQ)

What is the current Amplia Therapeutics Limited share price?

The current share price of Amplia Therapeutics Limited is AUD 0.047

How many Amplia Therapeutics Limited shares are in issue?

Amplia Therapeutics Limited has 513,312,014 shares in issue

What is the market cap of Amplia Therapeutics Limited?

The market capitalisation of Amplia Therapeutics Limited is AUD 24.13M

What is the 1 year trading range for Amplia Therapeutics Limited share price?

Amplia Therapeutics Limited has traded in the range of AUD 0.023 to AUD 0.23 during the past year

What is the PE ratio of Amplia Therapeutics Limited?

The price to earnings ratio of Amplia Therapeutics Limited is -8.23

What is the cash to sales ratio of Amplia Therapeutics Limited?

The cash to sales ratio of Amplia Therapeutics Limited is 14.46

What is the registered address of Amplia Therapeutics Limited?

The registered address for Amplia Therapeutics Limited is 90 William Street, Melbourne, Victoria, 3000

What is the Amplia Therapeutics Limited website address?

The website address for Amplia Therapeutics Limited is www.ampliatx.com

1plus1

I HAVE'NT BOUGHT BIEI FOR YEARS . WHAT LANGUAGE SHOULD YOU READ ?[/b

Couryset

Couryset 5分前

I bought Chinese ADRs because the growth stories were incredible. I didn't understand VIE structures, delisting risk, or regulatory crackdowns. When the Chinese government wiped out the education sector overnight, my £2,700 position went to £400. I hadn't even considered political risk. Laura G. Pre

infamous

infamous 5分前

sigh. worst stock and company ever

HappyLibrarian

HappyLibrarian 6分前

What is your formal role with the MHRA?

psych7

PR
PR about the conference presentation just came out.

otcstardmn

otcstardmn 6分前

$ATWT name change next nickel coming...

StonkMaster

StonkMaster 6分前

Northwest Biotherapeutics Announces Scientific Presentation on Propensity Score Matching at the British Neuro-Oncology Society Annual Meeting

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-scientific-presentation-on-propensity-score-matching-at-the-britis

KngmAz

I know that you're not buying because you're too stupid to be buying but you've created a huge buying opportunity for all of the smart people to be buying. Thank you.

Golden Cross

Golden Cross 7分前

Start of a new Qtr here, bet we see an influx of new buyers starting next week...

TRUSTUNITS1000000

TRUSTUNITS1000000 7分前

Who gets below 0.000001

1plus1

THE A/S WAS WAY BELOW 1.7 BIL A YEAR AGO ... WHY THE SPIKE ?? ... EMAILED THE CO " NO ANSWER "

PutzMueler

PutzMueler 8分前

Well, I didn’t say anything about a news release only that there was a new video that I couldn’t post

Couryset

Couryset 8分前

I tried to trade while going through a stressful divorce. My mind was everywhere except on my charts. I made impulsive decisions, revenge-traded after arguments, and lost £3,500 in three months. I was using the market as an emotional escape and it punished me. Laura G. Prescott on Facebook recognise

dexprs

Bought back 10 Covered Calls in FUTU for 20 cents were sold yesterday for 36 cents. Nibble, nibble.

TRUSTUNITS1000000

TRUSTUNITS1000000 8分前

Don’t let the shares outstanding scare you, this can run quickly

mars2063

mars2063 9分前

Lol mm is big scam

FormalMHRAconsultant

FormalMHRAconsultant 9分前

The CHM does advise the MHRA of their recommendation for rejection, but only after they have given the sponsor the opportunity to appeal. The CHM letter is sent to the sponsor, not the MHRA. The CHM's recommendation following the resolution of the CHM letter is what the CHM gives back to the MHRA.

TRUSTUNITS1000000

TRUSTUNITS1000000 9分前

Take it to 0.02 lol speculating

HappyLibrarian

HappyLibrarian 9分前

Just curious how much longer you intend to continue your sign-off before acting?

>>Let’s see it. I’ll be glad to be wrong.

As you suspect I am moving in the direction of selling out though NWBO shows that ‘moving in the direction’ means little in practical terms.

TRUSTUNITS1000000

TRUSTUNITS1000000 10分前

Ren has a lot of shares

Timing101

Timing101 10分前

$SRXH Well, This came out today on a SEC Filing for SRXH which is INTERESTING . Friday Market Closed for Holiday . Monday July 6 is THE GO DAY all are waiting to see and there are MANY OPINIONS. Go with the Facts out there , here is the Filing .
https://www.srxglobalinc.com/news-events/

Truenorth2016

Truenorth2016 10分前

Other Tickers have done the same, my post will be deleted if I start naming those companies...

Rainer

Rainer 10分前

SKFG .55 +385% otc

cintrix

cintrix 10分前

Don't forget Starlink: When most people think of SpaceX, they think of rockets and reusable launch systems. The numbers tell a different story. Starlink generated $11.4 billion in 2025 revenue, growing roughly 50% year over year and accounting for 61% of SpaceX's $18.7 billion in total revenue. In

1plus1

1plus1 10分前

I DID MONTHS AGO , DID'NT HELP

Amplia Therapeutics

New Amsterdam Invest NV

Cardiol Therapeutics

Arca US Treasury (GM)

5375% Sep 12 2033

Endeavour Silver

Altech Chemicals

Ls Short Volatility Long...

Tri City Bankshares (ID)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。